A phase I and biological correlates study of capecitabine (CAP) plus oxaliplatin (OX) plus radiation therapy (RT) in locally advanced rectal cancer (LARC).

被引：0

作者：

Fakih, MG ^{[1
]}

Rajput, A ^{[1
]}

Yang, GY ^{[1
]}

Pendyala, L ^{[1
]}

Toth, K ^{[1
]}

Lawrence, DD ^{[1
]}

Smith, JL ^{[1
]}

Soehnlein, NA ^{[1
]}

Flaherty, L ^{[1
]}

Rustum, YM ^{[1
]}

机构：

[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：279S / 279S

页数：1

共 50 条

[41] A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer
Kudo, Toshihiro
Takemasa, Ichiro
Hata, Tsuyoshi
Sakai, Daisuke
Takahashi, Hidekazu
Haraguchi, Naotsugu
Nishimura, Junichi
Hata, Taishi
Matsuda, Chu
Satoh, Taroh
Mizushima, Tsunekazu
Mori, Masaki
Doki, Yuichiro
ONCOLOGY, 2019, 97 (04) : 211 - 216
[42] Oxaliplatin plus capecitabine in combination with radiation therapy for treatment of cervical cancer: A phase II study
Levine, L.
Hatch, S.
Richardson, G.
Robinson-Bennett, B.
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S38 - S39
[43] A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer
Glynne-Jones, R
Sebag-Montefiore, D
Maughan, TS
Falk, SJ
McDonald, AC
ANNALS OF ONCOLOGY, 2006, 17 (01) : 50 - 56
[44] A Phase I Study of Capecitabine, Irinotecan, Celecoxib, and Radiation as Neoadjuvant Therapy of Patients With Locally Advanced Rectal Cancer
Malik, Imtiaz
Hussein, Farabi
Bush, David
Alqaisi, Munther
Bernal, Pedro
Byrd, Janet
Garberoglio, Carlos
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 242 - 245
[45] NEODJUVANT THERAPY WITH CAPECITABINE plus OXALIPLATIN AND CONCURRENT RADIOTHERAPY IN RECTAL CANCER
Fernandez, M. D. C.
Martin Jurado, E.
Rubio Jimenez, M.
RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S286 - S286
[46] Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma
Mehta, Rutika
Frakes, Jessica
Kim, Jongphil
Nixon, Andrew
Liu, Yingmiao
Howard, Lauren
Jimenez, Maria E. Martinez
Carballido, Estrella
Imanirad, Iman
Sanchez, Julian
Dessureault, Sophie
Xie, Hao
Felder, Seth
Sahin, Ibrahim
Hoffe, Sarah
Malafa, Mokenge
Kim, Richard
ONCOLOGIST, 2022, 27 (08): : 621 - E617
[47] A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer
Jo, Hyunji
Kim, Seung Tae
Lee, Jeeyun
Park, Se Hoon
Park, Joon Oh
Park, Young Suk
Lim, Ho Yeong
Yu, Jeong Il
Park, Hee Chul
Choi, Doo Ho
Park, Yoonah
Cho, Yong Beom
Huh, Jung Wook
Yun, Seong Hyeon
Kim, Hee Cheol
Lee, Woo Yong
Kang, Won Ki
CANCER RESEARCH AND TREATMENT, 2023, 55 (01): : 189 - 195
[48] Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study.
Michael, Michael
Mulcahy, Mary Frances
Deming, Dustin A.
Vaghefi, Houman
Jameson, Gayle S.
DeLuca, Angela
Xiong, Hao
Munasinghe, Wijith
Dudley, Matthew W.
Komarnitsky, Philip
Holen, Kyle D.
Czito, Brian G.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[49] Preliminary results of a phase I study of external beam radiation therapy (EBRT), oxaliplatin (OX), bevacizumab (BV), and capecitabine (CAP) for locally advanced or metastatic adenocarcinoma of the rectum.
Czito, B.
Bendell, J.
Willett, C.
Vaccaro, G.
Morse, M.
Yu, D.
Honeycutt, W.
Franklin, A.
Hurwitz, H.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 156S - 156S
[50] Phase II clinical trial of weekly oxaliplatin concurrent with capecitabine plus preoperative radiotherapy in locally advanced resectable rectal cancer
Majem, M.
Navarro, M.
Losa, F.
Alonso, V.
Gallen, M.
Benavides, M.
Rivera, F.
Escudero, P.
Massuti, B.
Aranda, E.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →